Cargando…
The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer
Objective: We assessed the prognostic implications of preoperative lymphocyte-monocyte ratio (LMR) in patients with endometrial cancer (EC). Methods: We retrospectively examined the LMR as a prognostic variable in a cohort of 255 patients with EC who underwent surgical resection. Patients were categ...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820730/ https://www.ncbi.nlm.nih.gov/pubmed/27053952 http://dx.doi.org/10.7150/jca.14206 |
_version_ | 1782425461637251072 |
---|---|
author | Eo, Wan Kyu Kwon, Sanghoon Koh, Suk Bong Kim, Min Jeong Ji, Yong Il Lee, Ji Young Suh, Dong Soo Kim, Ki Hyung Kim, Heung Yeol |
author_facet | Eo, Wan Kyu Kwon, Sanghoon Koh, Suk Bong Kim, Min Jeong Ji, Yong Il Lee, Ji Young Suh, Dong Soo Kim, Ki Hyung Kim, Heung Yeol |
author_sort | Eo, Wan Kyu |
collection | PubMed |
description | Objective: We assessed the prognostic implications of preoperative lymphocyte-monocyte ratio (LMR) in patients with endometrial cancer (EC). Methods: We retrospectively examined the LMR as a prognostic variable in a cohort of 255 patients with EC who underwent surgical resection. Patients were categorized into two groups according to the LMR (LMR-low and LMR-high) using cutoff points determined by receiving operator characteristic (ROC) curve analysis. The primary objective was to correlate the LMR to clinicopathological factors; the secondary objective was to determine the survival significance of the LMR in patients with EC. Results: Using data from the entire cohort, the most discriminative LMR cutoff value selected on the ROC curve was 3.28 for both disease-free survival (DFS) and overall survival (OS). The LMR-low and LMR-high groups included 33 (12.9%) and 222 patients (87.1%), respectively. The 5-year DFS rates in the LMR-low and LMR-high groups were 64.5 and 93.9% (P < 0.0001), respectively, and the 5-year OS rates in the two groups were 76.7 and 96.5% (P < 0.0001), respectively. On multivariate analysis, we identified histologic grade, International Federation of Gynecology and Obstetrics (FIGO) stage, and LMR levels as the strongest prognostic factors affecting DFS (P = 0.0037, P < 0.0001, and P < 0.0001, respectively), and FIGO stage and the LMR as the strongest prognostic factors predicting OS (P < 0.0001 and P < 0.0001, respectively). Conclusion: The LMR is an independent prognostic factor for both DFS and OS after surgical resection, and it provides additional prognostic value beyond standard clinicopathological parameters. |
format | Online Article Text |
id | pubmed-4820730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-48207302016-04-06 The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer Eo, Wan Kyu Kwon, Sanghoon Koh, Suk Bong Kim, Min Jeong Ji, Yong Il Lee, Ji Young Suh, Dong Soo Kim, Ki Hyung Kim, Heung Yeol J Cancer Research Paper Objective: We assessed the prognostic implications of preoperative lymphocyte-monocyte ratio (LMR) in patients with endometrial cancer (EC). Methods: We retrospectively examined the LMR as a prognostic variable in a cohort of 255 patients with EC who underwent surgical resection. Patients were categorized into two groups according to the LMR (LMR-low and LMR-high) using cutoff points determined by receiving operator characteristic (ROC) curve analysis. The primary objective was to correlate the LMR to clinicopathological factors; the secondary objective was to determine the survival significance of the LMR in patients with EC. Results: Using data from the entire cohort, the most discriminative LMR cutoff value selected on the ROC curve was 3.28 for both disease-free survival (DFS) and overall survival (OS). The LMR-low and LMR-high groups included 33 (12.9%) and 222 patients (87.1%), respectively. The 5-year DFS rates in the LMR-low and LMR-high groups were 64.5 and 93.9% (P < 0.0001), respectively, and the 5-year OS rates in the two groups were 76.7 and 96.5% (P < 0.0001), respectively. On multivariate analysis, we identified histologic grade, International Federation of Gynecology and Obstetrics (FIGO) stage, and LMR levels as the strongest prognostic factors affecting DFS (P = 0.0037, P < 0.0001, and P < 0.0001, respectively), and FIGO stage and the LMR as the strongest prognostic factors predicting OS (P < 0.0001 and P < 0.0001, respectively). Conclusion: The LMR is an independent prognostic factor for both DFS and OS after surgical resection, and it provides additional prognostic value beyond standard clinicopathological parameters. Ivyspring International Publisher 2016-02-20 /pmc/articles/PMC4820730/ /pubmed/27053952 http://dx.doi.org/10.7150/jca.14206 Text en © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. |
spellingShingle | Research Paper Eo, Wan Kyu Kwon, Sanghoon Koh, Suk Bong Kim, Min Jeong Ji, Yong Il Lee, Ji Young Suh, Dong Soo Kim, Ki Hyung Kim, Heung Yeol The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer |
title | The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer |
title_full | The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer |
title_fullStr | The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer |
title_full_unstemmed | The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer |
title_short | The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer |
title_sort | lymphocyte-monocyte ratio predicts patient survival and aggressiveness of endometrial cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820730/ https://www.ncbi.nlm.nih.gov/pubmed/27053952 http://dx.doi.org/10.7150/jca.14206 |
work_keys_str_mv | AT eowankyu thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kwonsanghoon thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kohsukbong thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kimminjeong thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT jiyongil thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT leejiyoung thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT suhdongsoo thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kimkihyung thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kimheungyeol thelymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT eowankyu lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kwonsanghoon lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kohsukbong lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kimminjeong lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT jiyongil lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT leejiyoung lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT suhdongsoo lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kimkihyung lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer AT kimheungyeol lymphocytemonocyteratiopredictspatientsurvivalandaggressivenessofendometrialcancer |